Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 13, 2001 - Issue 9
98
Views
2
CrossRef citations to date
0
Altmetric
Research Article

BIOPERSISTENCE, FIBER LENGTH, AND CANCER RISK ASSESSMENT FOR INHALED FIBERS

Pages 755-772 | Published online: 01 Oct 2008

REFERENCES

  • Asgharian, B., and Yu, C. P. 1988. Deposition of inhaled fibrous particles in the human lung. J. Aerosol Med. 1:37–50.
  • Asgharian, B., and Yu, C. P. 1989. Deposition of fibers in the rat lung.]. Aerosol Sci. 20:355–366.
  • Berman, D. W., Crump, K. S., Chatfield, E. J., Davis, J. M. G., and Jones, A. D. 1995. The sizes shapes and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal. 15:181–195.
  • Bernstein, D. M. 1998. The scientific and health related reasons for fiber classification by the EC. Proc. VD1 (Verein Deutscher lngenieure) Berichte 1417. Dusseldorf, Germany.
  • Bernstein, D. M., Morscheidt, C., Grimm, H. G., Thevenaz, P., and Teichert, U. 1996. Evaluation of soluble fibers using the inhalation biopersistence model, a nine-fiber comparison. lnhal. Toxicol. 8:345–385.
  • Berry, G. 1999. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. lnhal. Toxicol. 11:111–130.
  • Chemical Industry Institute of Toxicology. 1999. Formaldehyde. Hazard characterization and dose-response assessment for carcinogenicity by the route of inhalation, rev. ed. Research Triangle Park, NC: Chemical Industry Institute of Toxicology.
  • Davis, J. M. G. 1989. Mineral fiber carcinogenesis: experimental data relating to the importance of fiber type, size, deposition, dissolution and migration. In Non-occupational exposure to mineral fibers, eds. J. Bignon, J. Peto, and R. Saracci, pp. 33–46. Lyon: International Agency for Research on Cancer, pub. no. 90.
  • Davis, J. M. G., Beckett, S. T., Bolton, R. E., Collings, P., and Middleton, A. P. 1978. Mass and num-ber of fibers in the pathogenesis of asbestos-related lung disease in rats. Br. J. Cancer 37:673–688.
  • Eastes, W., and Hadley, J. G. 1995. Dissolution of fibers inhaled by rats. lnhal. Toxicol. 7:179–196.
  • Eastes, W., and Hadley, J. G. 1996. A mathematical model of fiber carcinogenicity and fibrosis in inhalation and intraperitoneal experiments in rats. Inhal. Toxicol. 8:323–343.
  • Everitt, J. I. 1994. Mechanisms of fiber-induced diseases: implications for the safety evaluation of syn-thetic vitreous fibers. Regul. Toxicol. Pharmacol. 20:568–575.
  • Hesterberg, T. W., and Barrett, J. C. 1985. Induction by asbestos fibers of anaphase abnormalities; Mechanism for aneuploidy induction and possible carcinogenesis. Carcinogenesis6:473–480.
  • Hesterberg, T. W., Butterick, C. J., Oshimura, M., Brody, A. R., and Barrett, J. C. 1986. Role of phagocytosis in Syrian hamster cell transformation and cytogenetic effects induced by asbestos and short and long glass fibers. Cancer Res. 46:5795–5802.
  • Hodgson, J. T., and Darnton, A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann. Occup. Hyg. 44:565–601.
  • IARC. 1988. Man-made mineral fibres and radon. IARC Monogr. Eval. Carcinogen. Risks Hum. 43. IARC. 1996. Mechanisms of fibre carcinogenesis. ARC Scientific Publications, vol. 140. Lyon: IARC. International Labour Organization. 1990. Safety in the use of mineral and synthetic fibres. Occupational Safety and Health Series 61. Geneva: ILO.
  • Korkina, L. G., Durnev, A. D., and Suslova, T. B. 1992. Oxygen radical mediated mutagenic effect of asbestos on human lymphocytes: Suppression by oxygen radical scavengers. Mutat. Res. 265: 245–253.
  • Maxim, L. D., Mast, R. W., Utell, M. J., Yu, C. P., Boymel, P. M., Zoitos, B. K., and Cason, J. E. 1999. Hazard assessment and risk analysis of two new synthetic vitreous fibers. ReguL ToxicoL Pharmacol. 30:54–74.
  • McConnell, E. I. 2000. A science-based paradigm for the classification of SVFs. ReguL Toxicol. Pharmacol. 23:14–21.
  • McConnell, E . E., Axten, C., Hesterberg, T. W., Chevalier, J., Miiller, W. C., Everitt, J., Oberdorster, G., Chase, G. R., Thevenaz, P., and Kotin, P. 1999. Studies on the inhalation toxi-cology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. InhaL ToxicoL 11:785–835.
  • Moolgavkar, S. H., Luebeck, E. G., Turim, J., and Hanna, L. 1999. Quantitative assessment of the risk of lung cancer associated with occupational exposure to refractory ceramic fibers. Risk Anal. 19:599–611.
  • Moolgavkar, S. H., Luebeck, E. G., Turim, J., and Brown, R. C. 2000. Lung cancer risk associated with exposure to man-made fibers. Drug Chem. ToxicoL 23:223–242.
  • Moolgavkar, S. H., Turim, J., Brown, R. C., and Luebeck, E. G. 2001a. Long man-made fibers and lung cancer risk. ReguL Toxicol. PharmacoL 33:138–146.
  • Moolgavkar, S. H., Turim, J., and Brown, R. C. 2001b. The power of the European Union protocol to test for carcinogenicity of inhaled fibers. Regul. Toxicol. Pharmacol. 33:350–355.
  • Pott, F. 1978. Some aspects of the dosimetry of the carcinogenic potency of asbestos and other fibrous dusts. Staub-Reinhalt. Luft38:486–490.
  • Pott, F., Roller, M., Kamino, K., and Bellmann, B. 1994. Significance of durability of mineral fibers for their toxicity and carcinogenic potency in the abdominal cavity of rats in comparison with the low sensitivity of inhalation studies. Environ. Health Perspect. 102\(suppl 5):1 45–150.
  • Searl, A. 1994. A review of the durability of inhaled fibres and options for the design of safer fibres. Ann. Occup. Hyg. 38:839–855.
  • Stanton, M. F., and Layard, M. 1978. The carcinogenicity of fibrous minerals. In Workshop on asbestos: Definitions and measurement methods, pp. 143-151. National Bureau of Standards Special Pub. 506. Washington, DC: U.S. Department of Commerce, National Bureau of Standards.
  • Stanton, M. F., Blackwell, R., and Miller, E. 1969. Experimental pulmonary carcinogenesis with asbestos. Am. Ind. Hyg. Assoc. J. 30:236–244.
  • Stanton, M. F., Layard, M., Tegeris, A., Miller, E., May, M., and Kent, E. 1977. Carcinogenicity of fibrous glass: pleural response in relation to fiber dimension.]. Natl. Cancer Inst. 58:587–603.
  • Vorwald, A. J., Durkan, T. M., and Pratt, P. C. 1951. Experimental studies of asbestosis. AMA Arch. Ind. Hyg. Occup. Med. 3:1–43.
  • Wagner, J. C. 1962. Experimental production of mesothelial tumors of the pleura by implantation of dusts in laboratory animals. Nature 196:180–181.
  • Yu, C. P., Zhang, L., Oberdorster, G., Mast, R. W., Glass, L. R., and Utell, M. J. 1994. Deposition modeling of refractory ceramic fibers in the rat lung.]. Aerosol Sci. 25:407–417.
  • Yu, C. P., Ding, Y. J., Zhang, L., Oberdorster, G., Mast, R. W., Maxim, L. D., and Utell, M. J. 1996. A clearance model of refractory ceramic fibers (RCF) in the rat lung including fiber dissolution and breakage.]. Aerosol Sci. 27:151–160.
  • Yu, C. P., Ding, Y. J., Zhang, L., Oberdorster, G., Mast, R. W., Maxim, L. D., and Utell, M. J. 1997. Retention modeling of refractory ceramic fibers (RCF) in humans. Regul. Toxicol. PharmacoL 25: 18–25.
  • Yu, C. P., Dai, Y. T., Boymel, P. M., Zoitos, B. K., Oberdorster, G., and Utell, M. J. 1998. A clearance model of man-made vitreous fibers (MMVFs) in the rat lung. Inhal. Toxicol. 10:253–274.
  • Zoitos, B. K., DeMeringo, A., Royer, E., Theloban, S., Bauer, J., Law, J., Boymel, P., Olsen, J. R., Christensen, V. R., Guldberg, M., Koenig, A. R., and Perander, M. 1997. In vitro measurement of fiber dissolution rate relevant to biopersistence at neutral pH: An interlaboratory round robin. InhaL Toxicol. 9:525–540.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.